文献速递腹部MR

多期动脉相磁共振成像对局灶性肝脏病变动脉强化模式的特征分析:肝细胞癌与局灶性结节增生的比较

Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia.
PubMed 文献 · Radiol Med · 2020-01-08

回顾性纳入2017年1月至10月52例连续接受肝细胞特异性对比剂(Gd-EOB-DTPA)三期动脉相MRI且诊断为肝细胞癌或局灶性结节增生的患者,由两名盲法阅片者独立评估,计算对比强化比(CER)与肝-病灶对比比(LLCR),并将病灶按视觉及LLCR峰值分为早期、中期和晚期动脉相组。结果显示肝细胞癌与局灶性结节增生的CER无显著差异(p > 0.05),LLCR在早期动脉相局灶性结节增生显著高于肝细胞癌(p = 0.01),肝细胞癌LLCR从早期至中期动脉相有意义的升高(p = 0.009),而局灶性结节增生LLCR从中期至晚期动脉相下降(p = 0.004)。结论认为局灶性结节增生的最佳显示见于早期和中期动脉相,而肝细胞癌最佳观察见于中期和晚期动脉相。

要点

  • 肝细胞癌与局灶性结节增生的对比强化比无显著差异(p > 0.05)。
  • 早期动脉相局灶性结节增生的肝-病灶对比比显著高于肝细胞癌(p = 0.01)。
  • 局灶性结节增生最佳显示见于早期和中期动脉相,肝细胞癌最佳观察见于中期和晚期动脉相。

核心结论

  • 局灶性结节增生的最佳显示见于早期和中期动脉相,而肝细胞癌最佳观察见于中期和晚期动脉相。

研究设计与样本

  • 回顾性收集2017年1月至2017年10月52例连续患者,均接受肝细胞特异性对比剂(Gd-EOB-DTPA)三期动脉相MRI,MRI诊断为肝细胞癌或局灶性结节增生。
  • 图像由两名盲法阅片者独立评估,计算对比强化比(CER)和肝-病灶对比比(LLCR),并将病灶按视觉及LLCR峰值分为早期动脉相、中期动脉相和晚期动脉相组。
  • 数据最终采用非参数检验分析。

诊断标准与关键数值

  • 对比强化比(CER)在肝细胞癌与局灶性结节增生患者间无显著差异(p > 0.05)。
  • 早期动脉相局灶性结节增生的LLCR显著高于肝细胞癌(p = 0.01),中期和晚期动脉相无显著差异(p = 0.20和p = 0.82)。
  • 肝细胞癌LLCR从早期至中期动脉相有意义的升高(p = 0.009),而局灶性结节增生LLCR从中期至晚期动脉相下降(p = 0.004)。
  • 基于LLCR峰值,17例(55%)局灶性结节增生归入早期动脉相组、11例(35%)归入中期组、仅3例(10%)归入晚期组;14例(34%)肝细胞癌归入早期组、13例(32%)归入中期组、14例(33%)归入晚期组。
  • 定性分析与LLCR在85%的病例中具有良好一致性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the features of arterial enhancement pattern of focal nodular hyperplasia (FNH) and hepatocellular carcinoma (HCC) by triple-phase arterial magnetic resonance imaging (MRI).

METHODS: Data were retrospectively collected from 52 consecutive patients who underwent triple-phase arterial MRI using hepatocyte-specific contrast agents (Gd-EOB-DTPA) from January 2017 to October 2017, with a MR imaging diagnosis of HCC or FNH. The images were independently assessed by two blinded readers. Contrast enhancement ratio (CER) and liver-to-lesion contrast ratio (LLCR) were calculated. The lesions were classified visually and also based on the peak of LLCR into the following groups: (1) early arterial, (2) middle arterial and (3) late arterial. Data were eventually analysed using nonparametric tests.

RESULTS: The CER analysis showed no significant difference between HCC and FNH patients (p > 0.05). LLCRFNH were significantly higher than LLCRHCC in the early arterial (p = 0.01), but not in the middle and late arterial phases (p = 0.20 and p = 0.82, respectively). LLCRHCC presented a meaningful increase from early to middle arterial phase (p = 0.009), whereas LLCRFNH showed a decrease from middle to late arterial phase (p = 0.004). Based on the peak of LLCR, 17 (55%) FNHs were classified into early, 11 (35%) in middle and only 3 (10%) in late arterial phase groups. Similarly, 14 (34%) HCCs were categorized into early, 13 (32%) in middle and 14 (33%) in late arterial phase groups. There was a good agreement between qualitative analysis and LLCR in 85% of cases.

CONCLUSION: The optimal visualization of FNH has been detected in early and middle arterial phases while HCC has been best observed during middle and late arterial phases.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Gatti M, Calandri M, Bergamasco L, et al. Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia. Radiol Med. 2020. PMID: 31916102. doi:10.1007/s11547-019-01127-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。